DRIVEN BY OUR INNOVATION

Serial Number 88642020
Registration 7122106
700

Registration Progress

Application Filed
Oct 4, 2019
Under Examination
Jul 7, 2020
Approved for Publication
May 12, 2020
Published for Opposition
May 12, 2020
Registered
Jul 25, 2023

Trademark Image

DRIVEN BY OUR INNOVATION

Basic Information

Serial Number
88642020
Registration Number
7122106
Filing Date
October 4, 2019
Registration Date
July 25, 2023
Published for Opposition
May 12, 2020
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jul 25, 2023
Registration
Registered
Classes
042 044

Rights Holder

CSL Behring L.L.C.

16
Address
1020 First Avenue
King of Prussia, PA 19406

Ownership History

CSL Behring L.L.C.

Original Applicant
16
King of Prussia, PA

CSL Behring L.L.C.

Owner at Publication
16
King of Prussia, PA

CSL Behring L.L.C.

Original Registrant
16
King of Prussia, PA

Legal Representation

Attorney
Scott D. Woldow

USPTO Deadlines

Next Deadline
1300 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20230725)
Due Date
July 25, 2029
Grace Period Ends
January 25, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

42 events
Date Code Type Description Documents
Jul 25, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jul 25, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jun 23, 2023 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Jun 22, 2023 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jun 15, 2023 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jun 14, 2023 IUAF S USE AMENDMENT FILED Loading...
Jun 14, 2023 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Dec 29, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 28, 2022 EX5G S SOU EXTENSION 5 GRANTED Loading...
Dec 9, 2022 EXT5 S SOU EXTENSION 5 FILED Loading...
Dec 28, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Dec 9, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 9, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 7, 2022 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jun 7, 2022 EXT4 S SOU EXTENSION 4 FILED Loading...
Jun 7, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 9, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 7, 2021 EX3G S SOU EXTENSION 3 GRANTED Loading...
Dec 7, 2021 EXT3 S SOU EXTENSION 3 FILED Loading...
Dec 7, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 9, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 7, 2021 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jun 7, 2021 EXT2 S SOU EXTENSION 2 FILED Loading...
Jun 7, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 6, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 4, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 4, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 4, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 7, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 12, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 12, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 22, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 25, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 20, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 20, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 20, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 13, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 13, 2020 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 13, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 9, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 8, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 8, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Providing medical and scientific research information in the field of health and pharmaceuticals; Medical laboratory services, namely, scientific testing and screening services for testing of human blood plasma for safety and quality; medical laboratory services regarding human blood plasma; Scientific research; product research and development services, including scientific, medical, pharmaceutical and blood products research and development services; pharmaceutical research and development; research and development of vaccines and medicines; Providing medical and scientific research information in the field of pharmaceuticals, clinical trials, blood conditions, blood illnesses and blood diseases, including via a global computer network; Providing medical and scientific research information in the field of clinical trials and pharmaceuticals
First Use Anywhere: Dec 21, 2021
First Use in Commerce: Dec 21, 2021
Class 044
Providing medical information and treatment information in the field of health; medical services; medical testing and screening services for diagnostic or treatment purposes; medical testing of human blood plasma for diagnostic or treatment purposes; collection of human blood plasma; medical services, namely, providing medical information concerning blood products, providing medical information concerning health products and services; health care, namely, providing health care information in person, via the internet, and through the distribution of printed matter
First Use Anywhere: Dec 21, 2021
First Use in Commerce: Dec 21, 2021

Classification

International Classes
042 044